UCB Pharma
Reports from UCB Pharma detail the recent activities
Published in Medical Verdicts and Law Weekly, May 10th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at UCB Pharma.
Report 1: The US Food and Drug Administration (FDA) has approved UCB's leading anti-epileptic drug Keppra(R) (levetiracetam), as adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in adults and children 6 years of age and older with idiopathic generalised epilepsy (IGE). In epidemiological studies generalized seizures account for about 40% of incidence cases, with generalized tonic-clonic seizures estimated at 23%.1 The new indication, which is the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AARP
Calls for Rx Marketing Reform to Lower Cost of Prescription Drugs - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters - Allergies
Allergy & Asthma Network Mothers of Asthmatics Exposes Potentially Dangerous Asthma Medications - Altus Pharmaceuticals
Altus Pharmaceuticals Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock - Altus Pharmaceuticals Inc.
Altus Pharmaceuticals Announces Closing of $88.5 Million Public Offering - American Tort Reform Association
Survey Shows Alabamans Expect Transparency, Accountability From Attorney General - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
